l carnitine mode of action l-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders A review of current evidence

the fetal redox systems are not fully developed, so the fetus could be very susceptible to hypoxia and oxidative damage if MB crosses the placenta

However, many athletes prefer not to self-inject

PLoS ONE 7:e34233

Zierath, J.R., Krook, A

Persistent aches lasting beyond 2-3 weeks of starting treatment may indicate unrelated conditions like viral infections, autoimmune disorders, or medication interactions requiring evaluation

References to clinical trials, body-weight outcomes, glucose-related measures, or other human endpoints are not claims about this product and do not indicate that it is intended for human or animal use